Internal Medicine Practice Questions — USMLE Step 2 CK — Page 73

Question 1441Question →

A medical resident is evaluating four different patients admitted to the general internal medicine service. Match each patient's clinical presentation with the most appropriate immediate diagnostic or therapeutic step based on current clinical guidelines.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct matches align each specific clinical syndrome with its most critical guideline-indicated management step: the COPD exacerbation with respiratory acidosis requires NIPPV; the DKA patient requires isotonic fluids and continuous insulin; the uncomplicated CAP patient requires targeted narrow-spectrum antibiotics; and the patient in suspected adrenal crisis requires immediate empiric hydrocortisone.

Each correct pair links a classic internal medicine presentation to its most critical, evidence-based intervention. The COPD patient meets strict criteria for NIPPV due to acute respiratory acidosis. The DKA patient strictly requires fluids and continuous insulin to correct the life-threatening metabolic acidosis. The CAP patient should receive standard empiric therapy based on modern antibiotic stewardship principles. The patient with suspected adrenal crisis requires immediate, empiric hydrocortisone administration.

Step-by-Step Solution

1

Evaluate the patient with COPD and severe hypercapnia.

Identified acute respiratory acidosis (pH 7.26) indicating failure of compensatory mechanisms.

Recognizing respiratory failure confirms the indication for NIPPV, which is proven to reduce mortality.

2

Evaluate the patient with type 1 diabetes and abdominal pain.

Identified diabetic ketoacidosis (DKA) with an anion-gap metabolic acidosis.

Recognizing DKA mandates immediate intravascular volume expansion and suppression of lipolysis/ketogenesis via continuous insulin.

3

Evaluate the patient with stable community-acquired pneumonia.

Identified a lack of specific risk factors for multidrug-resistant organisms.

Adhering to antibiotic stewardship principles prevents the inappropriate use of excessively broad-spectrum antibiotics (e.g., vancomycin/cefepime).

4

Evaluate the hypotensive patient with electrolyte derangements.

Identified the classic triad of hyponatremia, hyperkalemia, and hypotension highly suspicious for an adrenal crisis.

Delaying treatment for confirmatory labs in adrenal crisis significantly increases mortality; therefore, empiric corticosteroids are required immediately.

Key Concept

Acute guideline-based management of internal medicine emergencies, prioritizing stabilization and antibiotic stewardship.

Question 1442Question →

A 62-year-old woman comes to the emergency department complaining of progressively worsening shortness of breath and right-sided pleuritic chest pain over the past two weeks. She has a 12-year history of seropositive rheumatoid arthritis with severe joint deformities. Her current medications include methotrexate, etanercept, and folic acid. Her temperature is 37.2°C (99.0°F), blood pressure is 132/84 mmHg, pulse is 88/min, and respirations are 22/min. Oxygen saturation is 94% on room air. Physical examination reveals decreased breath sounds and dullness to percussion over the right lower lung field. Jugular venous pressure is 6 cm H2O. Cardiac auscultation shows a regular rate and rhythm with no murmurs or gallops. Examination of the hands shows ulnar deviation of the fingers and subluxation of the metacarpophalangeal joints. A chest radiograph demonstrates a moderate-sized right pleural effusion. A diagnostic thoracentesis is performed. Which of the following pleural fluid profiles is most characteristic of the pulmonary manifestation of this patient's underlying autoimmune disease?

Glucose concentration of 15 mg/dL and lactate dehydrogenase (LDH) of 850 U/L

Glucose concentration of 95 mg/dL and lactate dehydrogenase (LDH) of 110 U/L

Pleural fluid pH of 7.45 and total protein of 2.1 g/dL

Predominantly polymorphonuclear leukocytes with a positive Gram stain

Elevated triglyceride concentration greater than 110 mg/dL

Show answer & explanation

Answer: Glucose concentration of 15 mg/dL and lactate dehydrogenase (LDH) of 850 U/L

Answer

An exudative pleural fluid profile with a very low glucose concentration and high lactate dehydrogenase (LDH) is characteristic of rheumatoid pleuritis.

This patient with a long-standing history of severe rheumatoid arthritis (RA) is presenting with a right-sided pleural effusion. Pleural involvement (rheumatoid pleuritis) is a well-recognized extra-articular manifestation of RA, most commonly occurring in men and in patients with subcutaneous nodules and high rheumatoid factor titers. RA pleural effusions are characteristically exudative. What makes them unique is their specific biochemical profile: they typically exhibit a markedly low glucose concentration (often less than 30 mg/dL), an extremely high lactate dehydrogenase (LDH) level (often greater than 700 U/L), and a low pH (often less than 7.20). The low glucose is attributed to a localized block in glucose transport across the inflamed pleura combined with increased consumption by the prominent inflammatory cells in the fluid. Therefore, an exudative profile with a glucose of 15 mg/dL and highly elevated LDH strongly and specifically points to rheumatoid pleuritis.

Step-by-Step Solution

1

Analyze the clinical presentation and physical examination findings.

The patient has long-standing, severe rheumatoid arthritis (RA) and now presents with a unilateral pleural effusion without clinical signs of right heart failure (normal JVP) or systemic bacterial infection (afebrile).

Establishing the pre-test probability of an extra-articular manifestation of rheumatoid arthritis versus a secondary complication like heart failure or pneumonia.

2

Identify the specific biochemical characteristics of rheumatoid pleural effusions.

Rheumatoid pleuritis classically produces an exudative effusion characterized by a very low glucose level (< 30 mg/dL), a high LDH level (> 700 U/L), and a low pH (< 7.20).

This specific profile is caused by defective glucose transport across the inflamed pleura and high metabolic consumption by inflammatory cells, which helps differentiate RA effusions from other exudates.

3

Evaluate the given answer choices against known pleural fluid profiles.

The profile featuring a glucose of 15 mg/dL and LDH of 850 U/L perfectly matches the classic findings of an RA pleural effusion.

The other options represent transudates, bacterial empyema, or chylothorax, which are inconsistent with the patient's presentation of a sterile autoimmune effusion.

Key Concept

Rheumatoid pleuritis typically presents as an exudative pleural effusion characterized by profoundly low glucose levels (< 30 mg/dL), high lactate dehydrogenase (LDH) levels, and low pH.

Estimated Time:1m 15s

Question 1443Question →

Match each clinical vignette describing an immunocompromised patient with an infectious disease to the most appropriate targeted antimicrobial therapy, taking into account patient-specific contraindications.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Each scenario requires bypassing the standard first-line antimicrobial agent due to a critical, patient-specific contraindication: use isavuconazole to avoid QTc prolongation in aspergillosis, pentamidine to avoid hemolysis in G6PD-deficient severe PCP, amikacin to avoid beta-lactam anaphylaxis in ESBL bacteremia, and foscarnet to avoid worsening neutropenia in CMV retinitis.

Correct matching relies on synthesizing the infectious diagnosis with critical pharmacological contraindications to select the single best alternative therapy.

Step-by-Step Solution

1

Evaluate the first vignette for diagnosis and contraindications.

Diagnosis: Invasive Aspergillosis. Contraindication: QTc 560 msec.

Voriconazole is standard but prolongs QTc. Isavuconazole must be selected because it uniquely shortens the QTc interval.

2

Evaluate the second vignette for severity, diagnosis, and contraindications.

Diagnosis: Severe Pneumocystis jirovecii pneumonia (PaO2 < 70 mmHg requires steroids). Contraindication: G6PD deficiency.

TMP-SMX, Dapsone, and Primaquine induce oxidative stress and hemolysis in G6PD deficiency. IV pentamidine is required for severe disease.

3

Evaluate the third vignette for resistance patterns and allergies.

Diagnosis: ESBL E. coli bacteremia. Contraindication: Anaphylaxis to all beta-lactams.

Carbapenems are standard for ESBL, but the anaphylaxis history precludes their use. Aminoglycosides (Amikacin) offer non-beta-lactam bactericidal coverage.

4

Evaluate the fourth vignette for viral etiology and drug toxicities.

Diagnosis: CMV retinitis. Contraindication: Pre-existing severe neutropenia (ANC 400).

Ganciclovir causes dose-dependent bone marrow suppression. Foscarnet treats CMV effectively while avoiding further myelosuppression.

Key Concept

Antimicrobial Stewardship and High-Yield Drug Contraindications

Estimated Time:3m 0s

Question 1444Question →

A 36-year-old woman, who works as a pharmacist, is evaluated in the clinic for recurrent episodes of severe diaphoresis, confusion, and tremors. These episodes predominantly occur in the late afternoon after skipping meals and resolve rapidly after she consumes a carbohydrate-rich snack. Her physical examination is unremarkable. Renal and hepatic function tests are within normal limits. The physician suspects an underlying neuroendocrine pathology. Arrange the following clinical, diagnostic, and therapeutic steps in the most appropriate chronological sequence for the definitive evaluation and management of this patient's suspected condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: Documentation of Whipple triad -> Supervised 72-hour fast -> CT of the abdomen -> Endoscopic ultrasound -> Surgical enucleation.

The evaluation of suspected insulinoma follows a strict sequential protocol dictated by the Endocrine Society guidelines. First, the presence of a true hypoglycemic disorder is established by documenting Whipple triad (clinical). Second, the mechanism of hypoglycemia must be biochemically confirmed using a supervised 72-hour fast; in a healthcare worker, measuring C-peptide and screening for oral hypoglycemic agents is critical to rule out factitious disorder. Only after biochemical confirmation of endogenous hyperinsulinism does structural localization begin, adhering to the core endocrine principle of 'biochemistry before imaging.' Non-invasive imaging (CT/MRI) is utilized first. Because insulinomas are typically small (

< 2

cm), non-invasive imaging may be negative, necessitating invasive localization (EUS or selective arterial calcium stimulation). Once definitively localized, surgical enucleation or resection is performed.

Step-by-Step Solution

1

Document Whipple triad.

Confirms true clinical hypoglycemia.

Prevents extensive and dangerous workups in patients with pseudohypoglycemia or non-hypoglycemic autonomic symptoms.

2

Perform a supervised 72-hour fast with biochemical panel.

Differentiates endogenous hyperinsulinism (elevated insulin and C-peptide, low beta-hydroxybutyrate) from factitious hypoglycemia (positive drug screen).

Biochemical etiology must be definitively proven before attempting to locate a tumor.

3

Obtain multiphasic contrast-enhanced CT of the abdomen.

Provides first-line non-invasive structural localization of the suspected insulinoma.

Non-invasive imaging is always the initial radiologic step after biochemical confirmation.

4

Perform an Endoscopic Ultrasound (EUS).

Provides high-resolution invasive localization for small tumors not visible on CT.

Reserved for cases where non-invasive modalities fail, preventing blind surgical exploration.

5

Perform surgical enucleation.

Removes the insulin-secreting tumor.

Provides definitive curative therapy once the exact location is known.

Key Concept

The diagnostic and therapeutic algorithm for suspected insulinoma requires establishing clinical hypoglycemia, followed by biochemical confirmation of endogenous hyperinsulinism, non-invasive imaging, invasive imaging (if needed), and finally surgical resection.

Estimated Time:2m 0s

Question 1445Question →

During morning rounds in the intensive care unit, a 71-year-old man is evaluated for persistent lethargy and a mildly decreased heart rate. He was admitted 6 days prior for severe community-acquired pneumonia that was complicated by septic shock. His initial management required mechanical ventilation and vasopressor support. Currently, his clinical status has significantly improved; he was successfully extubated yesterday and vasopressors were discontinued 48 hours ago. The patient is completing a targeted course of intravenous ceftriaxone for blood cultures that grew *Streptococcus pneumoniae* sensitive to all tested beta-lactams. He has no known history of thyroid disease or other endocrine disorders.

Vital signs currently show a temperature of 36.6°C (97.9°F), blood pressure of 118/74 mm Hg, pulse of 54/min, and respiratory rate of 16/min. Pulse oximetry is 98% on room air. On physical examination, he appears drowsy but is easily arousable and fully oriented. The thyroid gland is not palpable. Cardiopulmonary examination is notable only for mild bibasilar crackles. There is no nonpitting edema, and the relaxation phase of his deep tendon reflexes is normal.

Due to the bradycardia and lethargy, a laboratory evaluation is obtained, revealing the following:

Test	Result	Reference Range
Thyroid-stimulating hormone (TSH)	$0.2 \mu\text{U/mL}$	$0.4 - 4.0 \mu\text{U/mL}$
Total T3	$42 \text{ ng/dL}$	$80 - 200 \text{ ng/dL}$
Free T4	$1.1 \text{ ng/dL}$	$0.9 - 2.4 \text{ ng/dL}$
Cortisol (8:00 AM)	$26 \mu\text{g/dL}$	$5 - 23 \mu\text{g/dL}$

Which of the following is the most appropriate next step in management?

Observation without specific endocrine intervention

Initiation of intravenous levothyroxine

Administration of intravenous hydrocortisone

Magnetic resonance imaging of the pituitary gland

Escalation of antimicrobial therapy to piperacillin-tazobactam

Show answer & explanation

Answer: Observation without specific endocrine intervention

Answer

The most appropriate next step in management is observation without specific endocrine intervention.

The most appropriate next step in management is observation without specific endocrine intervention. This patient's laboratory findings (markedly low total T3, low-normal TSH, and normal free T4) in the context of resolving critical illness (recent septic shock) are highly characteristic of nonthyroidal illness syndrome (NTIS), also known as euthyroid sick syndrome. NTIS is primarily driven by decreased peripheral 5'-deiodination of T4 to active T3, which instead gets converted to inactive reverse T3 (rT3). As the severity or duration of the illness increases, TSH and free T4 levels may also decline. This phenomenon is widely considered a physiologic, adaptive response to severe metabolic stress that lowers the body's basal metabolic rate, rather than a true hypothyroid state. Treatment with exogenous thyroid hormone (levothyroxine or T3) does not improve clinical outcomes in critically ill patients and may actually be harmful by increasing the risk of arrhythmias or myocardial ischemia. Therefore, observation is the correct approach, and thyroid function tests should only be reassessed after the patient has fully recovered from the acute illness if clinical suspicion of thyroid dysfunction persists.

Step-by-Step Solution

1

Analyze the patient's clinical trajectory and current symptoms.

The patient is recovering from severe septic shock but exhibits residual lethargy and mild bradycardia, prompting a thyroid evaluation.

Establishing the context of recent severe, acute critical illness is essential for accurately interpreting endocrine laboratory anomalies.

2

Interpret the thyroid function tests and serum cortisol level.

The patient has a low total T3, a low-normal TSH, and a normal free T4. The morning cortisol is appropriately elevated at

26 \mu\text{g/dL}

.

This specific pattern must be differentiated from primary hypothyroidism (where TSH would be high) and central hypothyroidism (where cortisol might also be low if panhypopituitarism is present).

3

Synthesize the findings to formulate a diagnosis.

The combination of severe acute illness and isolated low T3 (with subsequent lowering of TSH and T4) indicates nonthyroidal illness syndrome (euthyroid sick syndrome).

Critical illness decreases the peripheral 5'-deiodination of T4 into active T3, favoring conversion into inactive reverse T3. This is a physiologic adaptation to stress.

4

Determine the appropriate clinical management based on the diagnosis.

The correct management is to observe the patient. Thyroid hormone replacement is contraindicated.

Studies have consistently shown that supplementing thyroid hormone in nonthyroidal illness syndrome does not improve survival or clinical outcomes, and it may cause harm.

Key Concept

Nonthyroidal illness syndrome (euthyroid sick syndrome) typically presents with low T3, normal or low T4, and low or normal TSH in critically ill patients. It is a physiologic adaptation requiring only observation, not thyroid hormone replacement.

Estimated Time:1m 30s

Question 1446Question →

A 62-year-old man is brought to the emergency department by his husband due to a 24-hour history of severe headache, high fever, and progressive confusion. He has a history of end-stage renal disease and underwent a deceased-donor renal transplantation 3 years ago. His current medications include tacrolimus, mycophenolate mofetil, and prednisone. His temperature is 39.2°C (102.6°F), blood pressure is 112/74 mmHg, pulse is 115/min, and respirations are 20/min. Physical examination reveals marked nuchal rigidity and lethargy. He is oriented to person only, but there are no focal neurologic deficits.

Arrange the following diagnostic and therapeutic steps in the most appropriate sequential order for the optimal management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first obtain blood cultures, immediately administer empiric antibiotics and dexamethasone, perform a head CT scan, perform a lumbar puncture, and finally narrow antimicrobial therapy based on results.

The most appropriate sequence of steps for this patient is obtaining blood cultures, administering empiric antibiotics and dexamethasone, performing a head CT, performing a lumbar puncture, and finally narrowing therapy based on results. This patient presents with suspected bacterial meningitis. Given his immunocompromised state (renal transplant) and altered mental status (confusion, lethargy), he has clear indications for a non-contrast head CT prior to a lumbar puncture (LP) to rule out a focal mass lesion and prevent brain herniation. Because the LP will be delayed by the CT scan, empiric antibiotics MUST be administered immediately. However, to maximize the chance of identifying the causative organism, two sets of blood cultures should be drawn just before the antibiotics are given. The empiric regimen includes dexamethasone, ceftriaxone, vancomycin, and ampicillin (for Listeria coverage). Once the CT scan clears the patient, the LP can be safely performed. Finally, therapy is targeted based on CSF culture and susceptibility results to practice sound antimicrobial stewardship.

Step-by-Step Solution

1

Identify the clinical syndrome and indications for neuroimaging.

The patient has signs of acute bacterial meningitis along with altered mental status and an immunocompromised state.

These findings are specific indications for obtaining a head CT before performing a lumbar puncture (LP) to avoid the risk of brain herniation.

2

Sequence the diagnostic and therapeutic interventions appropriately.

Blood cultures must be drawn first, followed immediately by empiric antimicrobial therapy, then head CT, and finally LP.

Delaying antibiotics for a head CT or LP significantly increases mortality. However, blood cultures must be drawn just before antibiotics to ensure the pathogen can be identified.

3

Select the appropriate empiric regimen.

Dexamethasone, ceftriaxone, vancomycin, and ampicillin are administered.

This broad-spectrum regimen covers Streptococcus pneumoniae, Neisseria meningitidis, Listeria monocytogenes (ampicillin is necessary due to his age and immunocompromised state), and resistant organisms.

4

Determine the final step in management.

Narrow antimicrobial therapy based on CSF analysis.

Once the specific pathogen and its susceptibilities are identified from the CSF, de-escalating antibiotics promotes antimicrobial stewardship and minimizes toxicity.

Key Concept

In patients with suspected bacterial meningitis who have indications for a head CT prior to lumbar puncture (e.g., immunocompromised state, altered mental status), empiric antibiotics and blood cultures must NOT be delayed while waiting for neuroimaging.

Question 1447Question →

A 35-year-old woman presents to the clinic with progressive weight gain, proximal muscle weakness, and easy bruising over the past eight months. Physical examination reveals central obesity, facial plethora, and wide, violaceous striae on her abdomen. The physician suspects Cushing syndrome. Arrange the following diagnostic steps in the correct chronological sequence to accurately establish the diagnosis and localize the etiology.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: confirm hypercortisolism, measure ACTH levels, perform high-dose dexamethasone testing (if ACTH-dependent), and finally obtain targeted imaging.

The diagnostic workup for Cushing syndrome relies on a strict progression from biochemical confirmation to anatomical localization. The physician must first confirm endogenous hypercortisolism. Second, ACTH is measured to categorize the disease as ACTH-dependent or independent. Third, high-dose suppression testing differentiates pituitary from ectopic sources. Finally, targeted imaging is ordered based on the biochemical evidence to avoid the trap of anatomical incidentalomas.

Step-by-Step Solution

1

Confirm hypercortisolism

Establishes the biochemical diagnosis of Cushing syndrome.

Prevents extensive workup in patients with normal cortisol physiology or pseudo-Cushing states.

2

Measure plasma ACTH

Differentiates ACTH-independent (adrenal) from ACTH-dependent (pituitary or ectopic) hypercortisolism.

Guides the subsequent biochemical tests and determines which organ system is driving the excess cortisol.

3

Perform high-dose dexamethasone suppression

Differentiates pituitary Cushing disease from ectopic ACTH secretion.

Pituitary adenomas retain some negative feedback mechanisms and will suppress cortisol production at high doses, whereas ectopic tumors (e.g., small cell lung cancer) will not.

4

Obtain targeted imaging

Anatomically localizes the biochemically proven tumor.

Imaging must be delayed until this step because benign, non-functioning incidentalomas of the pituitary and adrenal glands are common in the general population.

Key Concept

Diagnostic algorithm for Cushing syndrome

Estimated Time:1m 0s

Question 1448Question →

A 24-year-old man presents to the clinic complaining of a diffuse, nonpruritic maculopapular rash that involves his palms and soles, accompanied by mild malaise and generalized lymphadenopathy. He reports unprotected sexual contact with a new partner approximately ten weeks ago. You suspect a systemic sexually transmitted infection. Arrange the following steps in the most appropriate chronological order for the diagnostic evaluation, treatment, and ongoing management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological order is: Initial serologic screening test, followed by a complementary confirmatory serologic test, then administration of intramuscular benzathine penicillin G, and finally repeating quantitative nontreponemal testing at 6 and 12 months.

The proper clinical management of syphilis follows a strict protocol. First, an initial screening test (nontreponemal or treponemal depending on the local algorithm) is ordered. Because no single test is perfectly sensitive and specific, a positive screen must be followed by a confirmatory test using a different methodology to avoid treating false positives. Once the diagnosis of secondary syphilis is secure, the patient is treated with intramuscular benzathine penicillin G. Finally, because Treponema pallidum cannot be cultured, disease eradication is confirmed by monitoring quantitative nontreponemal titers (such as RPR) at 6 and 12 months, looking for a four-fold decrease.

Step-by-Step Solution

1

Perform an initial serologic screening test.

Identifies antibodies that may indicate a syphilis infection.

Both the traditional and reverse-sequence testing algorithms require a highly sensitive initial screen to capture all potential cases.

2

Perform a complementary confirmatory serologic test.

Establishes a definitive diagnosis of secondary syphilis.

Initial tests (especially nontreponemal tests like RPR) can be falsely positive due to autoimmune diseases, pregnancy, or other infections. A second test using a different methodology is mandatory to confirm the diagnosis.

3

Administer a single dose of intramuscular benzathine penicillin G.

Eradicates the active Treponema pallidum infection.

This is the definitive, curative treatment for early (primary, secondary, and early latent) syphilis.

4

Repeat quantitative nontreponemal serologic testing at 6 and 12 months.

Confirms therapeutic success and resolution of the disease.

A four-fold decline in nontreponemal titers indicates adequate treatment response. Treponemal tests cannot be used for this step as they usually remain positive for life.

Key Concept

The standard workflow for managing secondary syphilis involves two-step serologic diagnostic testing, immediate treatment with intramuscular penicillin upon confirmation, and long-term serologic monitoring to ensure cure.

Question 1449Question →

A 29-year-old woman comes to the clinic due to a 3-month history of intermittent heart palpitations, excessive sweating, and a 6-kg (13-lb) weight loss. She feels anxious and has had difficulty sleeping. The patient has no significant past medical history and takes no prescription medications. She works as a fitness instructor and admits to taking several online dietary supplements to "boost her metabolism." Her temperature is 37.1°C (98.8°F), blood pressure is 135/85 mm Hg, and pulse is 112/min. Physical examination reveals a fine tremor of the outstretched hands. Her thyroid gland is nonpalpable, and there is no exophthalmos or pretibial myxedema. Laboratory results show:

Laboratory Test	Result	Reference Range
Thyroid-stimulating hormone (TSH)	0.01 µU/mL	0.4 - 4.0 µU/mL
Free T4	0.5 ng/dL	0.9 - 1.7 ng/dL
Free T3	7.2 pg/mL	2.0 - 4.4 pg/mL

Which of the following is the most likely underlying cause of this patient's condition?

Exogenous ingestion of thyroxine

Autoantibody stimulation of the thyrotropin receptor

Exogenous ingestion of triiodothyronine

Inflammatory destruction of thyroid follicles

Compression of thyrotroph cells by a sellar mass

Show answer & explanation

Answer: Exogenous ingestion of triiodothyronine

Answer

Exogenous ingestion of triiodothyronine

The correct answer is exogenous ingestion of triiodothyronine (T3). This patient presents with clinical signs of thyrotoxicosis (tachycardia, tremor, sweating, weight loss). The laboratory results show a suppressed TSH and elevated Free T3, confirming hyperthyroidism. However, the Free T4 is surprisingly low. This specific pattern—suppressed TSH, low Free T4, and high Free T3—is the hallmark of factitious thyrotoxicosis caused by liothyronine (T3) abuse, often found in 'metabolism-boosting' weight loss supplements. The high circulating exogenous T3 exerts negative feedback on the anterior pituitary, severely suppressing TSH secretion. Without TSH stimulation, the endogenous thyroid gland halts production of both T4 and T3, leading to glandular atrophy (resulting in a nonpalpable thyroid on exam). Because T3 cannot be reverse-converted to T4 in the periphery, the serum Free T4 level falls below normal, while the Free T3 level remains high due to the exogenous intake.

Step-by-Step Solution

1

Evaluate the clinical presentation.

The patient has classic signs of thyrotoxicosis, including tachycardia, weight loss, tremor, and diaphoresis, along with a nonpalpable thyroid gland.

Establishing the clinical state (hyperthyroid vs. hypothyroid) is essential before interpreting the lab values.

2

Interpret the thyroid function tests.

TSH is suppressed, confirming the thyrotoxic state. Free T3 is markedly elevated, but Free T4 is abnormally low.

This specific dissociation (low T4 with high T3) narrows down the differential diagnosis significantly.

3

Correlate lab findings with pathophysiology to determine the underlying cause.

The combination of thyrotoxicosis, suppressed TSH, high Free T3, low Free T4, and a nonpalpable thyroid gland exclusively points to exogenous triiodothyronine (T3) use.

Exogenous T3 suppresses TSH. The lack of TSH stimulation leads to thyroid follicular atrophy (nonpalpable gland) and ceased endogenous T4 production. Since the body does not convert T3 back into T4, serum T4 levels drop while T3 remains high due to the supplements.

Key Concept

Diagnosis of factitious thyrotoxicosis due to exogenous liothyronine (T3) ingestion.

Alternative Method

When evaluating thyrotoxicosis without a palpable goiter, one can categorize by T4 levels: if T4 is high, consider thyroiditis or exogenous T4 (differentiate via thyroglobulin). If T4 is low but T3 is high, it is almost exclusively exogenous T3.

Estimated Time:1m 15s

Question 1450Question →

Match the following diuretic medications with their primary site and mechanism of action within the nephron.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Acetazolamide matches with the proximal convoluted tubule; Furosemide matches with the thick ascending limb; Hydrochlorothiazide matches with the early distal convoluted tubule; Spironolactone matches with the cortical collecting duct.

Each class of diuretics has a specific molecular target along the nephron, which determines its clinical indications, efficacy, and side effect profile.

Step-by-Step Solution

1

Identify the target for Acetazolamide

Proximal convoluted tubule

Acetazolamide inhibits carbonic anhydrase, which is predominantly located in the proximal convoluted tubule.

2

Identify the target for Furosemide

Thick ascending limb

Loop diuretics like furosemide block the Na+-K+-2Cl- cotransporter in the thick ascending limb of the loop of Henle.

3

Identify the target for Hydrochlorothiazide

Early distal convoluted tubule

Thiazide diuretics block the Na+-Cl- cotransporter located in the early segment of the distal convoluted tubule.

4

Identify the target for Spironolactone

Cortical collecting duct

Spironolactone acts as an aldosterone receptor antagonist in the principal cells of the cortical collecting duct.

Key Concept

Mechanisms and sites of action of diuretic classes

Estimated Time:45s

Question 1451Question →

A 24-year-old woman with a history of type 1 diabetes mellitus presents to the emergency department with a 3-day history of intractable nausea, vomiting, and diffuse abdominal pain. She reports that her insulin pump malfunctioned four days ago. On physical examination, she appears lethargic and has dry mucous membranes. Her pulse is 118/min, blood pressure is 98/60 mm Hg, and respirations are 26/min and deep.

Laboratory studies show:
Serum:
Sodium: $140 \text{ mEq/L}$
Potassium: $4.8 \text{ mEq/L}$
Chloride: $88 \text{ mEq/L}$
Bicarbonate: $16 \text{ mEq/L}$
Blood urea nitrogen: $42 \text{ mg/dL}$
Creatinine: $1.6 \text{ mg/dL}$
Glucose: $520 \text{ mg/dL}$

Arterial blood gas (room air):
pH: 7.34
$\text{pCO}_2$ : $31 \text{ mm Hg}$
$\text{pO}_2$ : $95 \text{ mm Hg}$

Assume a normal serum anion gap of $12 \text{ mEq/L}$ and a normal serum bicarbonate of $24 \text{ mEq/L}$ .

What is this patient's delta-delta ratio ( $\frac{\Delta \text{AG}}{\Delta \text{HCO}_3^-}$ )?

Show answer & explanation

Answer: 3

Answer

3.0

The correct answer is 3.0. The patient has a calculated anion gap of 36 mEq/L (140 - [88 + 16]). The change in anion gap (

\Delta

AG) is 24 mEq/L (36 - 12). The change in bicarbonate (

\Delta\text{HCO}_3^-

) is 8 mEq/L (24 - 16). The delta-delta ratio is

\Delta\text{AG} / \Delta\text{HCO}_3^- = 24 / 8 = 3.0

. In an uncomplicated high anion gap metabolic acidosis (HAGMA), the drop in bicarbonate should roughly equal the rise in the anion gap, yielding a ratio between 1.0 and 2.0. A ratio greater than 2.0 indicates that the bicarbonate level is higher than expected, signaling a concurrent metabolic alkalosis. This is consistent with the patient's history of intractable vomiting (loss of gastric HCl) in the setting of diabetic ketoacidosis.

Step-by-Step Solution

1

Calculate the serum anion gap.

36 mEq/L

To identify the presence and magnitude of an unmeasured anion accumulation (high anion gap metabolic acidosis).

2

Calculate the delta anion gap (

\Delta\text{AG}

).

24 mEq/L

To determine how much the anion gap has increased above the normal baseline.

3

Calculate the delta bicarbonate (

\Delta\text{HCO}_3^-

).

8 mEq/L

To determine how much the serum bicarbonate has decreased from the normal baseline.

4

Calculate the delta-delta ratio (

\frac{\Delta\text{AG}}{\Delta\text{HCO}_3^-}

).

3.0

To evaluate for the presence of a concurrent mixed acid-base disorder.

Key Concept

Delta-delta ratio in the evaluation of mixed acid-base disorders

Estimated Time:1m 30s

Question 1452Question →

A $68$ -year-old man is evaluated in the intensive care unit for a drop in his platelet count. He was admitted $7$ days ago for a massive pulmonary embolism and was subsequently started on an unfractionated heparin infusion. His past medical history is significant for hypertension and type $2$ diabetes mellitus. Today, his platelet count is $95,000/\text{mm}^3$ , a decrease from $280,000/\text{mm}^3$ on admission. Physical examination reveals a new, painful, erythematous skin lesion with a necrotic center at a recent subcutaneous injection site on his abdomen. Laboratory studies show:

Laboratory Test	Result
Hemoglobin	$11.2\text{ g/dL}$
Platelets	$95,000/\text{mm}^3$
Leukocytes	$8,500/\text{mm}^3$
Blood urea nitrogen	$48\text{ mg/dL}$
Serum creatinine	$3.1\text{ mg/dL}$
Prothrombin time	$12\text{ sec}$
Activated partial thromboplastin time	$65\text{ sec}$

The patient's baseline serum creatinine was $1.1\text{ mg/dL}$ on admission. A screening test for platelet factor 4 (PF4)-heparin complex antibodies is pending. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

Discontinue unfractionated heparin and initiate argatroban

Discontinue unfractionated heparin and initiate fondaparinux

Discontinue unfractionated heparin and initiate enoxaparin

Discontinue unfractionated heparin and initiate warfarin

Continue unfractionated heparin and transfuse platelets

Show answer & explanation

Answer: Discontinue unfractionated heparin and initiate argatroban

Answer

Discontinue unfractionated heparin and initiate argatroban

The correct answer is to discontinue unfractionated heparin and initiate argatroban. This patient has a classic presentation of Type 2 Heparin-Induced Thrombocytopenia (HIT), defined by a >50% drop in platelet count occurring 5 to 10 days after heparin exposure, along with a necrotic skin lesion at the injection site. HIT is a paradoxically prothrombotic condition caused by IgG autoantibodies against the heparin-platelet factor 4 (PF4) complex. Management requires immediate cessation of all heparin products and the initiation of a non-heparin parenteral anticoagulant. Because this patient has developed acute kidney injury (creatinine 3.1 mg/dL), argatroban is the anticoagulant of choice as it undergoes hepatic metabolism and clearance. Renally cleared agents should be avoided.

Step-by-Step Solution

1

Calculate the 4T score or assess the clinical probability of Heparin-Induced Thrombocytopenia (HIT).

The patient has a >50% drop in platelets, occurring 5-10 days after heparin initiation, with a classic necrotic skin lesion at the injection site. This indicates a high probability of Type 2 HIT.

Recognizing the clinical syndrome of HIT is essential before waiting for confirmatory laboratory testing (PF4 antibodies or serotonin release assay), as immediate intervention is required.

2

Determine the initial management steps for highly suspected HIT.

All heparin products (including flushes) must be immediately discontinued, and a non-heparin parenteral anticoagulant must be started to prevent fatal thrombosis.

HIT is a highly prothrombotic state; stopping heparin alone is insufficient, and alternative anticoagulation is mandatory.

3

Evaluate the patient's current organ function to select the safest alternative anticoagulant.

The laboratory results show a serum creatinine of 3.1 mg/dL (up from a baseline of 1.1 mg/dL), indicating acute kidney injury.

Clearance mechanisms dictate drug safety. Non-heparin anticoagulants like fondaparinux and bivalirudin are renally cleared and pose a high risk of bleeding in acute kidney injury.

4

Select the appropriate alternative anticoagulant based on hepatic vs. renal clearance.

Argatroban is selected because it is a direct thrombin inhibitor that is metabolized and excreted by the liver.

Argatroban does not require dose adjustment for renal failure, making it the safest choice for this patient.

Key Concept

Management of Heparin-Induced Thrombocytopenia (HIT) with concurrent renal failure

Question 1453Question →

An evaluation for recurrent nephrolithiasis is being conducted for a 51-year-old male. Over the past six months, he has passed two calcium oxalate stones. He reports no major medical history but mentions a recent onset of constipation and generalized bone aches. Vital signs are within normal limits. Blood tests reveal a serum calcium concentration of $11.4$ mg/dL (normal: $8.4-10.2$ mg/dL) and a serum phosphorus concentration of $2.2$ mg/dL (normal: $2.7-4.5$ mg/dL). Which of the following is the most appropriate next step in the diagnostic evaluation of this patient's metabolic abnormality?

Measurement of intact parathyroid hormone (PTH)

Measurement of 1,25-dihydroxyvitamin D

24-hour urine calcium collection

Sestamibi parathyroid scan

Measurement of parathyroid hormone-related peptide (PTHrP)

Show answer & explanation

Answer: Measurement of intact parathyroid hormone (PTH)

Answer

Measurement of intact parathyroid hormone (PTH) is the most appropriate next step.

The correct response is the measurement of intact parathyroid hormone (PTH). In any patient with confirmed hypercalcemia, the first and most critical branching point in the diagnostic workup is determining whether the elevated calcium is PTH-mediated (primary or tertiary hyperparathyroidism, familial hypocalciuric hypercalcemia) or non-PTH-mediated (malignancy, vitamin D toxicity, granulomatous disease). Measuring intact PTH accurately establishes this distinction and dictates all subsequent steps.

Step-by-Step Solution

1

Identify the primary laboratory abnormality in the context of the patient's symptoms.

The patient has hypercalcemia (

11.4

mg/dL) and hypophosphatemia (

2.2

mg/dL), presenting with classic symptoms of 'stones, bones, and groans'.

Recognizing the metabolic state is necessary to select the correct diagnostic algorithm.

2

Determine the first branching point in the standard diagnostic algorithm for this laboratory abnormality.

The initial step in evaluating any hypercalcemia is to distinguish whether the condition is driven by the parathyroid glands (PTH-mediated) or by another source (non-PTH-mediated).

Measuring intact parathyroid hormone (PTH) is the most direct and accurate way to make this differentiation.

3

Select the option that matches this diagnostic protocol.

Measurement of intact parathyroid hormone (PTH) is selected as the correct next step.

This aligns exactly with medical guidelines for the workup of hypercalcemia.

Key Concept

The initial diagnostic step for any confirmed hypercalcemia is the measurement of serum intact parathyroid hormone (PTH) to differentiate between PTH-mediated and non-PTH-mediated causes.

Question 1454Question →

A 55-year-old woman comes to the clinic reporting progressive fatigue, cold intolerance, and a 4-kg (8.8-lb) weight gain over the past six months. She has a history of a nonfunctioning pituitary macroadenoma for which she underwent transsphenoidal resection two years ago. Vital signs show a heart rate of 55/min and blood pressure of 110/70 mm Hg. Physical examination reveals dry skin and delayed relaxation of deep tendon reflexes. Laboratory results are as follows:

TSH: 0.5 µU/mL (Reference: 0.4-4.0 µU/mL)
Free T4: 0.5 ng/dL (Reference: 0.9-1.7 ng/dL)

Which of the following is the most likely diagnosis?

Central hypothyroidism

Hashimoto thyroiditis

Subclinical hypothyroidism

Euthyroid sick syndrome

Resistance to thyroid hormone

Show answer & explanation

Answer: Central hypothyroidism

Answer

Central hypothyroidism

The correct answer is central hypothyroidism. The patient has clinical signs of hypothyroidism and a low free T4 level. In a normally functioning hypothalamic-pituitary-thyroid axis, a low free T4 should trigger a significant elevation in TSH due to the loss of negative feedback. This patient's TSH is inappropriately normal, indicating a failure of the pituitary gland to adequately respond to the low thyroid hormone levels. Her history of transsphenoidal resection for a pituitary macroadenoma makes pituitary failure (central hypothyroidism) the most likely diagnosis.

Step-by-Step Solution

1

Evaluate the patient's clinical presentation.

The patient exhibits classic symptoms and signs of hypothyroidism, including fatigue, cold intolerance, weight gain, bradycardia, and delayed relaxation of deep tendon reflexes.

Identifying the clinical syndrome guides the interpretation of the laboratory findings.

2

Interpret the thyroid function tests in the context of her surgical history.

The free T4 is low, confirming hypothyroidism. However, the TSH is inappropriately normal (0.5 µU/mL) rather than elevated. Combined with her history of pituitary resection, this indicates secondary/central failure.

In primary hypothyroidism, loss of negative feedback leads to a high TSH. A low T4 with a normal or low TSH indicates failure at the level of the pituitary or hypothalamus.

Key Concept

Central (secondary) hypothyroidism is characterized by a low free T4 level and an inappropriately normal or low TSH level, often due to pituitary or hypothalamic disease.

Question 1455Question →

A 26-year-old woman, G1P0, at 16 weeks gestation is evaluated during a routine prenatal visit. She reports mild fatigue over the past month but is otherwise feeling well. She has no significant past medical history. Current medications include a daily prenatal vitamin.

Vital signs are within normal limits. Physical examination reveals normal conjunctivae, no scleral icterus, and a gravid uterus consistent with gestational age.

Laboratory results are as follows:

Test	Result	Reference Range
Hemoglobin	$10.1\text{ g/dL}$	$12.0-15.5\text{ g/dL}$
Mean corpuscular volume (MCV)	$65\text{ fL}$	$80-100\text{ fL}$
Red blood cell (RBC) count	$5.8\text{ million/}\mu\text{L}$	$4.1-5.1\text{ million/}\mu\text{L}$
Platelets	$250,000\text{/}\mu\text{L}$	$150,000-400,000\text{/}\mu\text{L}$
Leukocytes	$8,500\text{/}\mu\text{L}$	$4,500-11,000\text{/}\mu\text{L}$
Serum iron	$95\text{ }\mu\text{g/dL}$	$60-170\text{ }\mu\text{g/dL}$
Total iron-binding capacity (TIBC)	$310\text{ }\mu\text{g/dL}$	$240-450\text{ }\mu\text{g/dL}$
Ferritin	$180\text{ ng/mL}$	$12-150\text{ ng/mL}$

Which of the following is the most appropriate next step in management?

Hemoglobin electrophoresis

Reassurance and continuation of routine prenatal care

Initiate oral ferrous sulfate therapy

Measure serum folate and vitamin B12 levels

Schedule a bone marrow aspiration

Show answer & explanation

Answer: Hemoglobin electrophoresis

Answer

The most appropriate next step is to perform hemoglobin electrophoresis to evaluate for thalassemia trait.

The patient presents with a profoundly microcytic anemia (MCV 65 fL) but has normal iron studies, including a ferritin level of 180 ng/mL, which effectively rules out iron deficiency. Furthermore, her red blood cell (RBC) count is elevated despite the low hemoglobin, yielding a Mentzer index (MCV/RBC count) of less than 13. This combination of severe microcytosis, an elevated RBC count, and normal to high iron stores is the classic presentation of thalassemia minor (trait). The definitive next step in management to confirm this diagnosis is hemoglobin electrophoresis, which typically demonstrates an elevated hemoglobin A2 fraction in beta-thalassemia trait.

Step-by-Step Solution

1

Analyze the complete blood count (CBC) results.

The patient has mild anemia (Hemoglobin 10.1 g/dL) with profound microcytosis (MCV 65 fL) and an elevated RBC count (5.8 million/µL).

To classify the morphology of the anemia based on red blood cell indices.

2

Evaluate the iron panel to distinguish the etiology of the microcytosis.

Serum iron, TIBC, and ferritin are all within or slightly above normal limits.

To rule out iron deficiency, which is the most common cause of microcytic anemia in pregnancy.

3

Synthesize findings to determine the most likely diagnosis.

Microcytic anemia with normal iron stores and an elevated RBC count (yielding a Mentzer index < 13) strongly suggests thalassemia minor (trait).

Differentiating between causes of microcytosis directs the next diagnostic or therapeutic step.

4

Select the appropriate diagnostic confirmation test.

Hemoglobin electrophoresis is indicated.

Electrophoresis separates hemoglobins and identifies abnormal variants or altered proportions (e.g., elevated HbA2 in beta-thalassemia trait).

Key Concept

Patients presenting with microcytic anemia, an elevated red blood cell count, and normal iron studies (normal or elevated ferritin) should be evaluated for thalassemia trait using hemoglobin electrophoresis.

Question 1456Question →

For each distinct laboratory and clinical profile in patients presenting with bleeding symptoms, match the most accurate underlying diagnosis.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct matches logically connect specific patterns of intrinsic, extrinsic, and common pathway coagulation defects with their classic hematologic disorders.

Each coagulation profile maps directly to a specific physiological part of the hemostatic pathway. Isolated correctable aPTT prolongation implies an intrinsic factor deficiency. Global cascade prolongation with thrombocytopenia indicates consumptive coagulopathy. Isolated PT prolongation zeroes in on the extrinsic pathway. Combined aPTT and bleeding time prolongation indicates concurrent primary and secondary hemostatic defects.

Step-by-Step Solution

1

Analyze the first profile showing isolated aPTT prolongation that corrects with a mixing study.

Points to an intrinsic pathway factor deficiency (Hemophilia).

A mixing study correction rules out autoantibodies (inhibitors), identifying a pure factor deficiency in the intrinsic cascade (Factor VIII, IX, XI, or XII).

2

Evaluate the second profile demonstrating global coagulation failure with thrombocytopenia.

Corresponds to a consumptive coagulopathy (DIC).

Sepsis triggers widespread tissue factor release, simultaneously consuming clotting factors and platelets while activating fibrinolysis.

3

Examine the third profile characterized by an isolated PT prolongation.

Indicates an isolated extrinsic pathway defect.

Factor VII is uniquely responsible for the extrinsic pathway; an isolated deficiency will only prolong the PT without affecting the aPTT or bleeding time.

4

Assess the fourth profile featuring combined primary (bleeding time) and secondary (aPTT) hemostasis defects.

Identifies von Willebrand disease.

vWF mediates initial platelet adhesion (primary hemostasis) and stabilizes Factor VIII in the plasma (secondary hemostasis), leading to this dual laboratory abnormality.

Key Concept

Interpretation of coagulation panels and platelet counts to diagnose inherited and acquired bleeding disorders.

Estimated Time:1m 30s

Question 1457Question →

A 65-year-old woman is hospitalized due to a 2-day history of high fever, right-sided flank pain, and altered mental status. She has a history of poorly controlled type 2 diabetes mellitus and recurrent urinary tract infections. On admission, her temperature is 39.2°C (102.6°F), blood pressure is 88/56 mm Hg, pulse is 118/min, and respirations are 22/min. Physical examination is notable for severe right costovertebral angle tenderness. Laboratory studies show a leukocyte count of 18,500/mm³. Urinalysis is positive for leukocyte esterase, nitrites, and numerous leukocytes. Blood and urine cultures are obtained, and the patient is started on empiric intravenous piperacillin-tazobactam. Over the next 48 hours, her fever resolves, and her hemodynamics normalize.

Preliminary results from both blood and urine cultures grow *Enterobacter cloacae*. Antimicrobial susceptibility testing reveals the isolate is susceptible to ceftriaxone, cefepime, piperacillin-tazobactam, meropenem, and gentamicin. It is resistant to ciprofloxacin and trimethoprim-sulfamethoxazole. Which of the following is the most appropriate next step in antimicrobial therapy?

Switch to intravenous ceftriaxone

Continue intravenous piperacillin-tazobactam

Switch to intravenous cefepime

Switch to intravenous meropenem

Add intravenous gentamicin to the current regimen

Show answer & explanation

Answer: Switch to intravenous cefepime

Answer

The most appropriate step is to switch the patient's therapy to intravenous cefepime.

The correct approach for treating invasive infections (e.g., bacteremia) caused by organisms with a high risk of clinically significant AmpC beta-lactamase production (such as *Enterobacter cloacae*, *Klebsiella aerogenes*, and *Citrobacter freundii*) is to use a fourth-generation cephalosporin, such as cefepime. Cefepime is highly stable against AmpC hydrolysis and is a weak inducer of the enzyme. Although carbapenems (like meropenem) are also highly effective, antimicrobial stewardship guidelines strongly recommend cefepime as a carbapenem-sparing targeted therapy for susceptible AmpC isolates.

Step-by-Step Solution

1

Identify the pathogen and its specific intrinsic resistance mechanisms.

The pathogen is *Enterobacter cloacae*, a classic organism known to harbor an inducible chromosomal AmpC beta-lactamase gene.

Recognizing the intrinsic resistance mechanisms of specific organisms is essential for safely interpreting laboratory susceptibility reports.

2

Interpret the susceptibility results in the context of the pathogen's AmpC production risk.

Although ceftriaxone and piperacillin-tazobactam show in vitro susceptibility, third-generation cephalosporins are strong inducers of AmpC and can lead to rapid hyperproduction and clinical failure in vivo.

In vitro susceptibility does not always guarantee in vivo clinical success, particularly with inducible beta-lactamase producers.

3

Select the optimal targeted therapy by balancing clinical efficacy and antimicrobial stewardship.

Cefepime, a fourth-generation cephalosporin, is highly stable against AmpC hydrolysis and is a weak inducer, making it the drug of choice. Meropenem is effective but should be reserved for cases where cefepime cannot be used.

Cefepime provides definitive, targeted therapy for invasive AmpC infections while adhering to stewardship principles by sparing overly broad-spectrum agents like carbapenems.

Key Concept

Management of invasive infections caused by moderate-to-high risk AmpC beta-lactamase-producing organisms (e.g., *Enterobacter cloacae*) requires avoiding third-generation cephalosporins despite in vitro susceptibility; cefepime is the preferred definitive therapy.

Question 1458Question →

Match each clinical scenario involving the use of a rheumatologic medication to its most critical associated toxicity, pharmacological interaction, or pre-treatment screening requirement.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct matching pairs are: Leflunomide with teratogenicity requiring cholestyramine washout; Rituximab with hepatitis B reactivation risk; Azathioprine with life-threatening pancytopenia risk when combined with allopurinol; Hydroxychloroquine with irreversible retinal toxicity risk; and TNF-alpha inhibitors with latent tuberculosis reactivation risk.

Each rheumatologic medication possesses a highly specific toxicity profile and mechanism of action that dictates its clinical management. Leflunomide requires a cholestyramine washout for pregnancy due to its long half-life. Rituximab profoundly depletes B cells, risking severe viral reactivation like HBV. Azathioprine metabolism is directly blocked by allopurinol, leading to severe pancytopenia. Hydroxychloroquine causes dose-dependent retinal toxicity requiring specialized OCT screening. Lastly, TNF-alpha inhibitors disrupt maintaining granulomas, necessitating screening for latent tuberculosis.

Step-by-Step Solution

1

Identify the pyrimidine synthesis inhibitor (leflunomide) and its specific pharmacokinetic property.

Leflunomide undergoes enterohepatic circulation causing a long half-life and is teratogenic, matching the need for cholestyramine washout.

Cholestyramine interrupts enterohepatic circulation, allowing safe drug elimination before pregnancy.

2

Identify the anti-CD20 monoclonal antibody (rituximab) and its infectious risks.

Rituximab causes profound B-cell depletion, matching the risk for hepatitis B reactivation and progressive multifocal leukoencephalopathy.

B cells are necessary for controlling certain latent viral infections.

3

Identify the purine analog (azathioprine) and its interaction with the patient's existing gout medication (allopurinol).

Allopurinol blocks xanthine oxidase, matching the risk of toxic azathioprine metabolite accumulation and fatal pancytopenia.

Xanthine oxidase is required to safely degrade 6-mercaptopurine (the active metabolite of azathioprine).

4

Identify the antimalarial agent (hydroxychloroquine) and its long-term monitoring requirements.

Hydroxychloroquine accumulates in melanin-rich tissues, matching the risk of bull's-eye maculopathy and the need for regular OCT screening.

Early detection of retinal toxicity prevents irreversible vision loss.

5

Identify the biologic agent causing apical lung cavitations (TNF-alpha inhibitor) and its pre-treatment requirement.

TNF-alpha inhibitors disrupt granulomas, matching the risk of tuberculosis reactivation and the need for IGRA screening.

TNF-alpha is essential for maintaining the granulomas that keep mycobacterial infections in a latent state.

Key Concept

Adverse effects, drug interactions, and pre-treatment screening requirements for disease-modifying antirheumatic drugs (DMARDs) and biologic agents.

Question 1459Question →

An internal medicine clinical pathways committee is updating hospital protocols for the acute management of oncologic complications. Match each of the following patient presentations—characterized by specific clinical signs, symptoms, and targeted laboratory data—to the single most appropriate initial therapeutic intervention according to current clinical guidelines.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct matches pair each oncologic emergency with its definitive initial management: malignant spinal cord compression requires immediate glucocorticoids; tumor lysis syndrome requires fluids and rasburicase; severe hypercalcemia requires aggressive saline followed by bisphosphonates; and febrile neutropenia requires immediate empiric antipseudomonal antibiotics.

The correct matches represent the consensus guidelines for acute oncologic emergencies. Suspected malignant spinal cord compression necessitates immediate corticosteroids to mitigate permanent neurologic damage. Tumor lysis syndrome requires vigorous hydration and rasburicase to address hyperuricemia and preserve renal function. Severe hypercalcemia requires initial aggressive isotonic saline to correct profound volume depletion before bisphosphonates take effect. Febrile neutropenia demands immediate blood cultures and the empiric initiation of an antipseudomonal beta-lactam to prevent fulminant sepsis.

Step-by-Step Solution

1

Analyze the first clinical presentation featuring progressive lower extremity weakness, a sensory level, and urinary retention in a patient with prostate cancer.

Identify the condition as malignant spinal cord compression (MSCC).

These findings represent a neurologic emergency requiring immediate intervention to prevent irreversible paralysis.

2

Determine the initial pharmacological step for malignant spinal cord compression.

Match with 'Immediate administration of high-dose intravenous glucocorticoids'.

Corticosteroids rapidly decrease spinal cord edema, relieving pressure while awaiting definitive imaging (MRI) and surgical or radiotherapeutic management.

3

Analyze the second presentation involving oliguria, peaked T waves, hyperuricemia, and hypocalcemia following chemotherapy.

Identify the condition as tumor lysis syndrome (TLS).

Massive tumor cell death releases intracellular contents (potassium, phosphate, and nucleic acids which convert to uric acid) into the bloodstream, precipitating acute kidney injury.

4

Determine the appropriate management for established tumor lysis syndrome.

Match with 'Continuous telemetry, aggressive isotonic fluid resuscitation, and administration of rasburicase'.

Aggressive fluid hydration maintains urine output, telemetry monitors hyperkalemia-induced arrhythmias, and rasburicase enzymatically degrades uric acid to prevent renal tubule crystallization.

5

Analyze the third presentation marked by lethargy, constipation, short QT interval, and calcium > 14 mg/dL.

Identify severe hypercalcemia of malignancy.

Symptoms of severe hypercalcemia typically emerge at levels above 14 mg/dL and induce profound intravascular volume depletion via nephrogenic diabetes insipidus.

6

Select the initial management for severe hypercalcemia of malignancy.

Match with 'Rapid volume expansion with intravenous 0.9% saline and subsequent administration of zoledronic acid'.

Restoration of intravascular volume with normal saline is always the first step, subsequently paired with bisphosphonates to inhibit osteoclastic bone resorption.

7

Analyze the fourth presentation showing fever in the setting of severe chemotherapy-induced neutropenia without a focal source.

Identify febrile neutropenia.

An absolute neutrophil count < 500/μL combined with fever is a life-threatening immunologic emergency where typical signs of focal infection are often absent.

8

Identify the mandatory initial intervention for febrile neutropenia.

Match with 'Immediate procurement of blood cultures followed by prompt initiation of an antipseudomonal beta-lactam'.

Empiric antibiotics must be started within 60 minutes of presentation due to the high risk of rapid clinical deterioration from uncontained bacterial proliferation, particularly from Pseudomonas aeruginosa.

Key Concept

Recognition and appropriate initial pharmacological management of acute oncologic emergencies (Malignant Spinal Cord Compression, Tumor Lysis Syndrome, Severe Hypercalcemia, and Febrile Neutropenia).

Estimated Time:2m 0s

Question 1460Question →

During a routine follow-up at the nephrology clinic, a 42-year-old woman is evaluated for persistent hypokalemia and mild muscle weakness. She has a history of Sjögren syndrome and has had two episodes of calcium phosphate nephrolithiasis in the past five years. She reports no diarrhea, vomiting, or recent dietary changes. Her blood pressure is 118/76 mm Hg. Laboratory studies show:

Serum sodium: 140 mEq/L
Serum potassium: 2.9 mEq/L
Serum chloride: 115 mEq/L
Serum bicarbonate: 15 mEq/L
Blood urea nitrogen: 12 mg/dL
Serum creatinine: 0.8 mg/dL

Urine studies obtained simultaneously show:
Urine sodium: 55 mEq/L
Urine potassium: 25 mEq/L
Urine chloride: 60 mEq/L

What is this patient's urine anion gap in mEq/L? (Provide your answer as a number only)

Show answer & explanation

Answer: 20

Answer

20

The patient has a normal anion gap metabolic acidosis (NAGMA), indicated by a serum anion gap of 10 mEq/L (

140 - (115 + 15)

). To evaluate the underlying cause of a NAGMA, the urine anion gap (UAG) is calculated to estimate renal ammonium (

NH_4^+

) excretion. The formula is:

UAG = (U_{Na} + U_{K}) - U_{Cl}

. Using the patient's values:

UAG = (55 + 25) - 60 = 80 - 60 = 20

mEq/L. In normal physiology and gastrointestinal bicarbonate loss (e.g., diarrhea), the kidneys increase

NH_4^+

production, which is excreted with chloride, resulting in a negative UAG. A positive UAG, as seen in this patient, indicates a failure of the kidneys to excrete adequate acid, which is diagnostic for renal tubular acidosis (RTA). Her history of Sjögren syndrome and calcium phosphate stones further points to Type 1 (distal) RTA.

Step-by-Step Solution

1

Calculate the serum anion gap.

Serum AG =

140 - (115 + 15) = 10

mEq/L.

Confirms the presence of a normal anion gap metabolic acidosis (NAGMA), prompting the need for a urine anion gap.

2

Set up the urine anion gap formula.

UAG = (U_{Na} + U_{K}) - U_{Cl}

The formula estimates unmeasured urinary ammonium excretion.

3

Insert the provided urine electrolyte values.

UAG = (55 + 25) - 60

Accurate substitution of variables is required for the calculation.

4

Perform the final calculation.

80 - 60 = 20

mEq/L

Yields the correct numerical answer indicating impaired ammonium excretion.

Key Concept

The urine anion gap (

UAG = U_{Na} + U_{K} - U_{Cl}

) differentiates renal from gastrointestinal causes of normal anion gap metabolic acidosis. A positive value reflects impaired urinary ammonium excretion, characteristic of distal renal tubular acidosis.

Internal Medicine

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Alternative Method

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution